Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases

Journal of Experimental Medicine

Volumn 203, Issue 10, 2006, Pages 2293-2303

  Gadola, Stephan D ^a,d   Silk, Jonathan D ^a   Jeans, Aruna ^b,e   Illarionov, Petr A ^c   Salio, Mariolina ^a   Besra, Gurdyal S ^c   Dwek, Raymond ^b   Butters, Terry D ^b   Platt, Frances M ^b,e   Cerundolo, Vincenzo ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GLYCOSPHINGOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; LYSOSOME STORAGE DISEASE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD1D; CELL DIFFERENTIATION; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; GLYCOSPHINGOLIPIDS; KILLER CELLS, NATURAL; LIGANDS; LYSOSOMAL STORAGE DISEASES; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTE SUBSETS;

EID: 33749346679     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060921     Document Type: Article

References (41)

1. Taniguchi, M., M. Harada, S. Kojo, T. Nakayama, and H. Wakao. 2003. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483-513.
2. Brigl, M., and M.B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22:817-890.
3. Bendelac, A. 1995. CD1: presenting unusual antigens to unusual T lymphocytes. Science. 269:185-186.
4. Naidenko, O.V., J.K. Maher, W.A. Ernst, T. Sakai, R.L. Modlin, and M. Kronenberg. 1999. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J. Exp. Med. 190:1069-1080.
5. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science. 306:1786-1789.
6. Mattner, J., K.L. Debord, N. Ismail, R.D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 434:525-529.
7. Park, S.H., K. Benlagha, D. Lee, E. Balish, and A. Bendelac. 2000. Unaltered phenotype, tissue distribution and function of Vα14(+) NKT cells in germ-free mice. Eur. J. Immunol. 30:620-625.
8. van Der Vliet, H.J., N. Nishi, T.D. de Gruijl, B.M. von Blomberg, A.J. van den Eertwegh, H.M. Pinedo, G. Giaccone, and R.J. Scheper. 2000. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood. 95:2440-2442.
9. Jayawardena-Wolf, J., K. Benlagha, Y.H. Chiu, R. Mehr, and A. Bendelac. 2001. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity. 15:897-908.
10. Chiu, Y.H., S.H. Park, K. Benlagha, C. Forestier, J. Jayawardena-Wolf, P.B. Savage, L. Teyton, and A. Bendelac. 2002. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 3:55-60.
11. Schuette, C.G., T. Doering, T. Kolter, and K. Sandhoff. 1999. The glycosphingolipidoses-from disease to basic principles of metabolism. Biol. Chem. 380:759-766.
12. Jeyakumar, M., T.D. Butters, R.A. Dwek, and F.M. Platt. 2002. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathol. Appl. Neurobiol. 28:343-357.
13. Loftus, S.K., J.A. Morris, E.D. Carstea, J.Z. Gu, C. Cummings, A. Brown, J. Ellison, K. Ohno, M.A. Rosenfeld, D.A. Tagle, et al. 1997. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science. 277:232-235.
14. Hopwood, J.J., A.C. Crawley, and R.M. Taylor. 2004. Spontaneous and engineered mammalian storage disease models. In Lysosomal Disorders of the Brain: Recent Advances in Molecular and Cellular Pathogenesis and Treatment. F. Platt and S. Walkley, editors. Oxford University Press, Oxford. 257-289.
15. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091-2096.
16. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171:5140-5147.
17. Hermans, I.F., J.D. Silk, J. Yang, M.J. Palmowski, U. Gileadi, C. McCarthy, M. Salio, F. Ronchese, and V. Cerundolo. 2004. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Methods. 285:25-40.
18. Yu, K.O., J.S. Im, A. Molano, Y. Dutronc, P.A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, et al. 2005. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc. Natl. Acad. Sci. USA. 102:3383-3388.
19. Wolf, P.R., and H.L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 11:267-306.
20. Prigozy, T.I., O. Naidenko, P. Qasba, D. Elewaut, L. Brossay, A. Khurana, T. Natori, Y. Koezuka, A. Kulkarni, and M. Kronenberg. 2001. Glycolipid antigen processing for presentation by CD1d molecules. Science. 291:664-667.
21. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science. 296:553-555.
22. + CD1d-dependent precursor stage. J. Exp. Med. 195:835-844.
23. Benlagha, K., D.G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202:485-492.
24. Gapin, L., J.L. Matsuda, C.D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:971-978.
25. Matsuda, J.L., L. Gapin, S. Sidobre, W.C. Kieper, J.T. Tan, R. Ceredig, C.D. Surh, and M. Kronenberg. 2002. Homeostasis of Vα14i NKT cells. Nat. Immunol. 3:966-974.
26. Sagiv, Y., K. Hudspeth, J. Mattner, N. Schrantz, R.K. Stern, D. Zhou, P.B. Savage, L. Teyton, and A. Bendelac. 2006. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J. Immunol. 177:26-30.
27. Zhou, D., C. Cantu III, Y. Sagiv, N. Schrantz, A.B. Kulkarni, X. Qi, D.J. Mahuran, C.R. Morales, G.A. Grabowski, K. Benlagha, et al. 2004. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science. 303:523-527.
28. Chen, C.S., M.C. Patterson, C.L. Wheatley, J.F. O'Brien, and R.E. Pagano. 1999. Broad screening test for sphingolipid-storage diseases. Lancet. 354:901-905.
29. Kolter, T., and K. Sandhoff. 2005. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21:81-103.
30. Balreira, A., L. Lacerda, C.S. Miranda, and F.A. Arosa. 2005. Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC-class II: monocytes from Gaucher disease patients as a model. Br. J. Haematol. 129:667-676.
31. Yamanaka, S., M.D. Johnson, A. Grinberg, H. Westphal, J.N. Crawley, M. Taniike, K. Suzuki, and R.L. Proia. 1994. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA. 91:9975-9979.
32. Jeyakumar, M., D. Smith, E. Eliott-Smith, M. Cortina-Borja, G. Reinkensmeier, T.D. Butters, T. Lemm, K. Sandhoff, V.H. Perry, R.A. Dwek, and F.M. Platt. 2002. An inducible mouse model of late onset Tay-Sachs disease. Neurobiol. Dis. 10:201-210.
33. Sango, K., M.P. McDonald, J.N. Crawley, M.L. Mack, C.J. Tifft, E. Skop, C.M. Starr, A. Hoffmann, K. Sandhoff, K. Suzuki, and R.L. Proia. 1996. Mice lacking both subunits of lysosomal β-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Nat. Genet. 14:348-352.
34. Ohshima, T., G.J. Murray, W.D. Swaim, G. Longenecker, J.M. Quirk, C.O. Cardarelli, Y. Sugimoto, I. Pastan, M.M. Gottesman, R.O. Brady, and A.B. Kulkarni. 1997. α-Galactosidase A deficient mice: a model of Fabry disease. Proc. Natl. Acad. Sci. USA. 94:2540-2544.
35. Hahn, C.N., M. del Pilar Martin, M. Schroder, M.T. Vanier, Y. Hara, K. Suzuki, and A. d'Azzo. 1997. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase. Hum. Mol. Genet. 6:205-211.
36. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vá14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
37. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
38. Platt, F.M., G.B. Karlsson, and G.S. Jacob. 1992. Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycin. Eur. J. Biochem. 208:187-193.
39. Karadimitris, A., S. Gadola, M. Altamirano, D. Brown, A. Woolfson, P. Klenerman, J.L. Chen, Y. Koezuka, I.A. Roberts, D.A. Price, et al. 2001. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA. 98:3294-3298.
40. Svennerholm, L., and P. Fredman. 1980. A procedure for the quantitative isolation of brain gangliosides. Biochim. Biophys. Acta. 617:97-109.
41. Neville, D.C., V. Coquard, D.A. Priestman, D.J. te Vruchte, D.J. Sillence, R.A. Dwek, F.M. Platt, and T.D. Butters. 2004. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem.331:275-282.